China Disease Control: COVID-19 Situation Overall Stable

The COVID-19 situation in China appears to be stabilizing, according to recent reports from the nation’s disease control agency. While the country experienced a significant shift in its pandemic management strategy beginning in January 8, 2023, moving away from its stringent “dynamic zero-COVID” policy, the transition has been characterized as “scientific, gradual, and cautious.”

For nearly three years, China implemented a strict zero-COVID approach, utilizing measures like border closures and lockdowns to suppress the virus’s spread. This policy proved successful in keeping COVID-19 largely at bay within mainland China for an extended period, a contrast to the substantial human and social costs experienced elsewhere in the world. However, the policy faced increasing challenges starting in early 2022.

The change in strategy involved reclassifying COVID-19 management from a Class A to a Class B infectious disease, signaling a reopening of the country. This decision was supported by several factors, including increased healthcare capacity, widespread vaccination efforts, and improved prevention and control mechanisms. According to a report from the Chinese Center for Disease Control and Prevention, hospitalization rates peaked following the policy change, but the overall approach aimed for a measured and controlled reopening.

Globally, the circulation of SARS-CoV-2, the virus that causes COVID-19, remains under surveillance. Data from the week of January 12 to January 18, 2026, indicates that out of 69,420 samples tested across 82 countries, 4.1% tested positive. While overall activity is described as stable and low, elevated activity or increases were reported in several regions, including Temperate South America, parts of Europe, Western Africa, Western and Southern Asia, and Oceania Melanesia Polynesia. This ongoing surveillance is coordinated by the World Health Organization (WHO) through its global network of sentinel and systematic virologic surveillance sites.

The shift in China’s approach, and the global surveillance efforts, reflect an evolving understanding of COVID-19. The initial outbreak in Wuhan in early 2020 prompted a rapid and decisive response from China, initially proving effective in containing the virus. However, the long-term sustainability of the zero-COVID policy came into question, leading to the adjustments implemented in January 2023.

Innovative public health strategies were crucial in responding to the pandemic worldwide. China’s response encompassed multiple areas, including infrastructure development, medical care and treatment protocols, disease prevention and control measures, economic and social resilience planning, and engagement in global health initiatives. The country’s experience provides valuable insights into the complexities of pandemic management and the need for adaptable strategies.

The integration of SARS-CoV-2 surveillance into existing respiratory disease surveillance systems is a key development. More countries are now reporting COVID-19 infections to the Global Influenza Surveillance and Response System (GISRS), enhancing the global picture of viral activity. However, it’s important to acknowledge data limitations when interpreting this information, as reporting practices and surveillance capabilities vary across different nations.

The current situation in China, as reported by national authorities, suggests a period of overall stability in terms of infectious disease epidemiology. This follows a period of significant change and adaptation in the country’s approach to managing the COVID-19 pandemic. Continued monitoring and surveillance, both within China and globally, remain essential to track the virus’s evolution and inform public health responses.

The WHO COVID-19 dashboard provides a comprehensive overview of reported data on SARS-CoV-2 activity and the burden of the disease, offering a valuable resource for tracking the pandemic’s trajectory worldwide. This data is submitted by Member States’ Ministries of Health and provides insights into cases, deaths, hospitalizations, vaccination rates, and the emergence of new variants.